美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

EyePoint

4.99

+0.12002.46%

成交量：217.14萬

成交額：1,118.65萬

市值：4.30億

市盈率：-1.33

高：5.29

開：4.98

低：4.96

收：4.87

52周最高：19.11

52周最低：3.95

股本：8,621.21萬

流通股本：6,067.44萬

量比：0.39

換手率：3.58%

股息：- -

股息率：- -

每股收益(TTM):-3.7642

每股收益(LYR):-3.1667

淨資產收益率：-148.70%

總資產收益率：-74.85%

市淨率：2.59

市盈率(LYR):-1.58

資料載入中...

總覽公司新聞資訊公告

BUZZ——美國股市動態-Dynatrace、Duolingo、百度公司

眼科管線失利刷屏，貝達藥業20CM跌停，公司回應

EyePoint股價下跌，因試驗性藥物未達預期，券商下調評級

美國研究綜述-Everpure、Marvell Technology、Okta

貝達藥業20CM跌停，EyePoint美股隔夜大跌67%，伏羅尼布wAMD三期臨床失敗，貝達藥業擁有大中華區權益。

EyePoint股價料將創下歷史最大跌幅，因其一款實驗性眼科藥物未能達到後期臨床試驗目標

EyePoint公司治療年齡相關性眼病的藥物晚期臨床試驗失敗，股價暴跌

EyePoint眼科藥物在後期臨床試驗中未達到主要目標

EyePoint公布Lugano試驗頂線數據——濕性AMD候選藥物Duravyu™ 2.7Mg兩項關鍵III期臨床研究首項結果揭曉

EyePoint 2026年第二季度財報：三期投入擴大淨虧損

TradingKey中文

EyePoint宣佈Duravyu™兩類關鍵性III期臨床試驗完成受試者入組，旨在治療糖尿病性黃斑水腫（DME）

EyePoint的晚期眼科藥物臨床試驗將在安全委員會審查後繼續進行

EyePoint宣佈Duravyu™濕性年齡相關性黃斑變性三期試驗獲獨立數據監查委員會第三次積極建議，為2026年中頂線數據增添信心

美國研究綜述-弗格森企業、哈特福德保險集團、摩根大通

EyePoint 起訴競爭對手 Ocular Therapeutix，稱其虛假宣傳眼科藥物

EyePoint公司遭起訴：指控涉及誹謗、商業詆譭及侵權干擾

訴訟指控Ocular Therapeutix就EyePoint及Duravyu發布虛假聲明——SEC文件披露

EyePoint公司於2026年3月20日向馬薩諸塞州米德爾塞克斯縣高等法院對Ocular Therapeutix提起訴訟

EyePoint宣佈Duravyu™治療糖尿病黃斑水腫的兩項全球三期臨床試驗首批患者完成給藥

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrdive.com/hant/stock/EYPT/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"EYPT","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"EYPT\",,,,,undefined,":{"symbol":"EYPT","market":"US","secType":"STK","nameCN":"EyePoint","latestPrice":4.99,"timestamp":1787679153868,"preClose":4.87,"halted":0,"volume":2171354,"delay":0,"changeRate":0.024640657084188933,"floatShares":60674399,"shares":86212138,"eps":-3.764176,"marketStatus":"交易中","change":0.12,"latestTime":"08-25 13:32:36 EDT","open":4.98,"high":5.285,"low":4.96,"amount":11186459.705944,"amplitude":0.066735,"askPrice":5,"askSize":600,"bidPrice":4.99,"bidSize":498,"shortable":3,"etf":0,"ttmEps":-3.764176,"tradingStatus":2,"nextMarketStatus":{"tag":"盤後交易","tradingStatus":3,"beginTime":1787688000000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":4.87,"preHourTrading":{"tag":"盘前","latestPrice":4.9219,"preClose":4.87,"latestTime":"09:29 EDT","volume":19641,"amount":97220.082414,"timestamp":1787664587058,"change":0.0519,"changeRate":0.010657,"amplitude":0.034908},"postHourTrading":{"tag":"盘后","latestPrice":4.86,"preClose":4.87,"latestTime":"19:51 EDT","volume":264865,"amount":1290618.4401,"timestamp":1787615466070,"change":-0.01,"changeRate":-0.002053,"amplitude":0.022587},"volumeRatio":0.389119,"impliedVol":1.6084,"impliedVolPercentile":0.749},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"EYPT\",,,,,undefined,":{"symbol":"EYPT","floatShares":60674399,"roa":"-74.85%","roe":"-148.70%","lyrEps":-3.166673,"volumeRatio":0.389119,"shares":86212138,"dividePrice":0,"high":5.285,"amplitude":0.066735,"preClose":4.87,"low":4.96,"week52Low":3.95,"pbRate":"2.59","psRate":"154.30","week52High":19.11,"institutionHeld":0.6176,"latestPrice":4.99,"committee":-0.092896,"eps":-3.764176,"divideRate":0,"volume":2171354,"delay":0,"ttmEps":-3.764176,"open":4.98,"prevYearClose":18.27,"prevWeekClose":5.32,"prevMonthClose":12.25,"prevQuarterClose":14.3,"fiveDayClose":5.47,"twentyDayClose":11.96,"sixtyDayClose":13.58},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/EYPT\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-05","symbol":"EYPT","fiscalQuarterEnding":"2026/06","expectedEps":-0.92,"name":null,"time":"盤前","type":"earning","dateTimestamp":1785902400000,"reportTimeType":"pre","actualEps":-1.09},{"market":"US","date":"2026-05-06","symbol":"EYPT","fiscalQuarterEnding":"2026/03","expectedEps":-0.79,"name":null,"time":"盤前","type":"earning","dateTimestamp":1778040000000,"reportTimeType":"pre","actualEps":-0.99},{"market":"US","date":"2026-03-04","symbol":"EYPT","fiscalQuarterEnding":"2025/12","expectedEps":-0.78,"name":null,"time":"盤前","type":"earning","dateTimestamp":1772600400000,"reportTimeType":"pre","actualEps":-0.81},{"market":"US","date":"2025-11-05","symbol":"EYPT","fiscalQuarterEnding":"2025/09","expectedEps":-0.77,"name":null,"time":"盤前","type":"earning","dateTimestamp":1762318800000,"reportTimeType":"pre","actualEps":-0.85},{"market":"US","date":"2025-08-06","symbol":"EYPT","fiscalQuarterEnding":"2025/06","expectedEps":-0.67,"name":null,"time":"盤前","type":"earning","dateTimestamp":1754452800000,"reportTimeType":"pre","actualEps":-0.85}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"EYPT\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"EYPT\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3077,"buy":0.3077,"hold":0.3846,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.3077,"analysts":13,"updateTime":1787284800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/EYPT\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"EYPT","date":"2026-08-24","current":-1.293776,"percent":0.94621,"low":-17.174537,"twenty":-7.129027,"median":-4.853357,"eighty":-2.791301,"high":-0.764844,"avg":-5.324275,"sd":3.010572,"marketCap":458648574},"quantilePoints":[{"date":"2021-08-27","current":-6.964065,"twenty":-4.472799,"median":-2.743614,"eighty":-1.930259,"marketCap":289426531},{"date":"2021-09-03","current":-7.628628,"twenty":-4.546098,"median":-2.75544,"eighty":-1.941719,"marketCap":317045763},{"date":"2021-09-10","current":-7.102515,"twenty":-4.61979,"median":-2.759953,"eighty":-1.956547,"marketCap":295180538},{"date":"2021-09-17","current":-7.642473,"twenty":-4.694611,"median":-2.760901,"eighty":-1.971028,"marketCap":317621164},{"date":"2021-09-24","current":-8.113205,"twenty":-4.731269,"median":-2.77201,"eighty":-1.988007,"marketCap":337184786},{"date":"2021-10-01","current":-7.760156,"twenty":-4.841039,"median":-2.78384,"eighty":-1.998647,"marketCap":322512069},{"date":"2021-10-08","current":-7.137128,"twenty":-4.919907,"median":-2.790917,"eighty":-2.015619,"marketCap":296619040},{"date":"2021-10-15","current":-7.919374,"twenty":-4.938321,"median":-2.79725,"eighty":-2.019761,"marketCap":329129177},{"date":"2021-10-22","current":-8.313958,"twenty":-4.971427,"median":-2.804116,"eighty":-2.02816,"marketCap":345528096},{"date":"2021-10-29","current":-7.940141,"twenty":-5.098544,"median":-2.833605,"eighty":-2.028584,"marketCap":329992278},{"date":"2021-11-05","current":-7.455146,"twenty":-5.185586,"median":-2.834547,"eighty":-2.038548,"marketCap":405962535},{"date":"2021-11-12","current":-7.40231,"twenty":-5.288363,"median":-2.838221,"eighty":-2.041297,"marketCap":403085408},{"date":"2021-11-19","current":-10.730609,"twenty":-5.348044,"median":-2.838221,"eighty":-2.041297,"marketCap":584324577},{"date":"2021-11-26","current":-10.288687,"twenty":-5.475735,"median":-2.838221,"eighty":-2.041297,"marketCap":560260166},{"date":"2021-12-03","current":-9.043837,"twenty":-5.543465,"median":-2.838221,"eighty":-2.041297,"marketCap":492473092},{"date":"2021-12-10","current":-9.050061,"twenty":-5.631762,"median":-2.838221,"eighty":-2.041297,"marketCap":492812027},{"date":"2021-12-17","current":-8.502327,"twenty":-5.718585,"median":-2.850463,"eighty":-2.041297,"marketCap":462985715},{"date":"2021-12-23","current":-8.43386,"twenty":-5.736973,"median":-2.850463,"eighty":-2.041297,"marketCap":459257426},{"date":"2021-12-31","current":-7.618483,"twenty":-5.783171,"median":-2.850463,"eighty":-2.041297,"marketCap":414856892},{"date":"2022-01-07","current":-8.782418,"twenty":-5.864553,"median":-2.850463,"eighty":-2.041984,"marketCap":478237807},{"date":"2022-01-14","current":-6.180681,"twenty":-5.916223,"median":-2.850463,"eighty":-2.041984,"marketCap":336562822},{"date":"2022-01-21","current":-5.439995,"twenty":-5.918806,"median":-2.850463,"eighty":-2.041984,"marketCap":296229513},{"date":"2022-01-28","current":-5.40265,"twenty":-5.918806,"median":-2.850463,"eighty":-2.041984,"marketCap":294195901},{"date":"2022-02-04","current":-5.813451,"twenty":-5.931903,"median":-2.850463,"eighty":-2.041984,"marketCap":316565635},{"date":"2022-02-11","current":-6.224251,"twenty":-5.976705,"median":-2.850463,"eighty":-2.041984,"marketCap":338935370},{"date":"2022-02-18","current":-5.639172,"twenty":-6.042095,"median":-2.850463,"eighty":-2.041984,"marketCap":307075445},{"date":"2022-02-25","current":-5.801002,"twenty":-6.042095,"median":-2.850463,"eighty":-2.041984,"marketCap":315887764},{"date":"2022-03-04","current":-6.637487,"twenty":-6.076834,"median":-2.850463,"eighty":-2.041984,"marketCap":387742063},{"date":"2022-03-11","current":-7.652837,"twenty":-6.099766,"median":-2.850463,"eighty":-2.041984,"marketCap":447055753},{"date":"2022-03-18","current":-7.447927,"twenty":-6.135388,"median":-2.850467,"eighty":-2.041984,"marketCap":435085578},{"date":"2022-03-25","current":-7.401305,"twenty":-6.148738,"median":-2.850472,"eighty":-2.041984,"marketCap":432362038},{"date":"2022-04-01","current":-7.080776,"twenty":-6.15825,"median":-2.850472,"eighty":-2.041984,"marketCap":413637698},{"date":"2022-04-08","current":-6.96422,"twenty":-6.180751,"median":-2.853843,"eighty":-2.041984,"marketCap":406828847},{"date":"2022-04-14","current":-7.395477,"twenty":-6.19313,"median":-2.860806,"eighty":-2.041984,"marketCap":432021595},{"date":"2022-04-22","current":-7.290577,"twenty":-6.210376,"median":-2.860806,"eighty":-2.041984,"marketCap":425893630},{"date":"2022-04-29","current":-6.585969,"twenty":-6.244501,"median":-2.860806,"eighty":-2.041984,"marketCap":384732546},{"date":"2022-05-06","current":-5.646366,"twenty":-6.277913,"median":-2.87084,"eighty":-2.041984,"marketCap":378944534},{"date":"2022-05-13","current":-5.017301,"twenty":-6.277913,"median":-2.87084,"eighty":-2.041984,"marketCap":336726095},{"date":"2022-05-20","current":-4.824523,"twenty":-6.277913,"median":-2.87084,"eighty":-2.041984,"marketCap":323788187},{"date":"2022-05-27","current":-4.915839,"twenty":-6.277913,"median":-2.87084,"eighty":-2.041984,"marketCap":329916670},{"date":"2022-06-03","current":-4.59116,"twenty":-6.277913,"median":-2.87084,"eighty":-2.041984,"marketCap":308126508},{"date":"2022-06-10","current":-4.017899,"twenty":-6.277913,"median":-2.87084,"eighty":-2.041984,"marketCap":269653253},{"date":"2022-06-17","current":-4.007753,"twenty":-6.277913,"median":-2.87084,"eighty":-2.041984,"marketCap":268972311},{"date":"2022-06-24","current":-3.678001,"twenty":-6.277913,"median":-2.869838,"eighty":-2.041297,"marketCap":246841678},{"date":"2022-07-01","current":-3.931656,"twenty":-6.277913,"median":-2.869838,"eighty":-2.041297,"marketCap":263865242},{"date":"2022-07-08","current":-4.185311,"twenty":-6.277913,"median":-2.869838,"eighty":-2.041297,"marketCap":280888806},{"date":"2022-07-15","current":-5.027447,"twenty":-6.277913,"median":-2.871843,"eighty":-2.041297,"marketCap":337407038},{"date":"2022-07-22","current":-5.428222,"twenty":-6.277913,"median":-2.876614,"eighty":-2.041297,"marketCap":364304269},{"date":"2022-07-29","current":-4.631745,"twenty":-6.277913,"median":-2.897069,"eighty":-2.041297,"marketCap":310850278},{"date":"2022-08-05","current":-4.689345,"twenty":-6.277913,"median":-2.902765,"eighty":-2.041297,"marketCap":358777096},{"date":"2022-08-12","current":-4.947637,"twenty":-6.277913,"median":-2.918529,"eighty":-2.041297,"marketCap":378538797},{"date":"2022-08-19","current":-4.680438,"twenty":-6.277913,"median":-2.955067,"eighty":-2.041297,"marketCap":358095658},{"date":"2022-08-26","current":-4.578012,"twenty":-6.277913,"median":-2.981219,"eighty":-2.041297,"marketCap":350259121},{"date":"2022-09-02","current":-4.123773,"twenty":-6.277913,"median":-3.01561,"eighty":-2.041297,"marketCap":315505784},{"date":"2022-09-09","current":-3.990174,"twenty":-6.277913,"median":-3.047288,"eighty":-2.041297,"marketCap":305284215},{"date":"2022-09-16","current":-3.638389,"twenty":-6.277913,"median":-3.074739,"eighty":-2.041297,"marketCap":278369506},{"date":"2022-09-23","current":-3.206414,"twenty":-6.277913,"median":-3.090207,"eighty":-2.041297,"marketCap":245319516},{"date":"2022-09-30","current":-3.522602,"twenty":-6.277913,"median":-3.110217,"eighty":-2.041297,"marketCap":269510746},{"date":"2022-10-07","current":-2.743265,"twenty":-6.277913,"median":-3.117347,"eighty":-2.041297,"marketCap":209884474},{"date":"2022-10-14","current":-2.493877,"twenty":-6.277913,"median":-3.117347,"eighty":-2.041297,"marketCap":190804068},{"date":"2022-10-21","current":-2.596305,"twenty":-6.277913,"median":-3.117347,"eighty":-2.041297,"marketCap":198640663},{"date":"2022-10-28","current":-2.444891,"twenty":-6.277913,"median":-3.117347,"eighty":-2.041297,"marketCap":187056130},{"date":"2022-11-04","current":-2.291539,"twenty":-6.277913,"median":-3.117347,"eighty":-2.041297,"marketCap":179276232},{"date":"2022-11-11","current":-2.017077,"twenty":-6.277913,"median":-3.117347,"eighty":-2.037196,"marketCap":157803984},{"date":"2022-11-18","current":-1.568353,"twenty":-6.277913,"median":-3.117347,"eighty":-2.028584,"marketCap":122698562},{"date":"2022-11-25","current":-1.44637,"twenty":-6.277913,"median":-3.117347,"eighty":-2.028584,"marketCap":113155340},{"date":"2022-12-02","current":-1.476866,"twenty":-6.277913,"median":-3.117347,"eighty":-2.020056,"marketCap":115541146},{"date":"2022-12-09","current":-1.267752,"twenty":-6.277913,"median":-3.117347,"eighty":-2.016865,"marketCap":99181337},{"date":"2022-12-16","current":-1.076065,"twenty":-6.277913,"median":-3.117347,"eighty":-2.005257,"marketCap":84184846},{"date":"2022-12-23","current":-1.259039,"twenty":-6.277913,"median":-3.117347,"eighty":-1.998555,"marketCap":98499679},{"date":"2022-12-30","current":-1.524788,"twenty":-6.277913,"median":-3.117347,"eighty":-1.991624,"marketCap":119290269},{"date":"2023-01-06","current":-1.420231,"twenty":-6.277913,"median":-3.117347,"eighty":-1.975507,"marketCap":111110364},{"date":"2023-01-13","current":-2.195695,"twenty":-6.277913,"median":-3.117347,"eighty":-1.963772,"marketCap":171777987},{"date":"2023-01-20","current":-1.834102,"twenty":-6.277913,"median":-3.117347,"eighty":-1.951722,"marketCap":143489152},{"date":"2023-01-27","current":-2.060642,"twenty":-6.277913,"median":-3.110217,"eighty":-1.94839,"marketCap":161212277},{"date":"2023-02-03","current":-2.021433,"twenty":-6.277913,"median":-3.099225,"eighty":-1.94839,"marketCap":158144813},{"date":"2023-02-10","current":-1.768754,"twenty":-6.277913,"median":-3.099225,"eighty":-1.939746,"marketCap":138376712},{"date":"2023-02-17","current":-1.503005,"twenty":-6.277913,"median":-3.099225,"eighty":-1.928219,"marketCap":117586122},{"date":"2023-02-24","current":-1.428944,"twenty":-6.277913,"median":-3.099225,"eighty":-1.918005,"marketCap":111792023},{"date":"2023-03-03","current":-1.086611,"twenty":-6.277913,"median":-3.099225,"eighty":-1.903097,"marketCap":111110364},{"date":"2023-03-10","current":-0.811808,"twenty":-6.277913,"median":-3.099225,"eighty":-1.876527,"marketCap":83010660},{"date":"2023-03-17","current":-0.788326,"twenty":-6.277913,"median":-3.099225,"eighty":-1.862926,"marketCap":80609526},{"date":"2023-03-24","current":-0.764844,"twenty":-6.277913,"median":-3.099225,"eighty":-1.844212,"marketCap":78208391},{"date":"2023-03-31","current":-0.986247,"twenty":-6.277913,"median":-3.098122,"eighty":-1.833959,"marketCap":100847662},{"date":"2023-04-06","current":-1.014761,"twenty":-6.277913,"median":-3.099225,"eighty":-1.830785,"marketCap":103763326},{"date":"2023-04-14","current":-1.298223,"twenty":-6.277913,"median":-3.096321,"eighty":-1.818062,"marketCap":132748453},{"date":"2023-04-21","current":-1.905402,"twenty":-6.277913,"median":-3.074739,"eighty":-1.806764,"marketCap":194834939},{"date":"2023-04-28","current":-2.101645,"twenty":-6.277913,"median":-3.057645,"eighty":-1.806764,"marketCap":214901566},{"date":"2023-05-05","current":-2.270232,"twenty":-6.25452,"median":-3.0294,"eighty":-1.806764,"marketCap":232567058},{"date":"2023-05-12","current":-2.136295,"twenty":-6.25452,"median":-3.000653,"eighty":-1.806764,"marketCap":218846287},{"date":"2023-05-19","current":-2.052584,"twenty":-6.25452,"median":-2.918529,"eighty":-1.806764,"marketCap":210270806},{"date":"2023-05-26","current":-1.985615,"twenty":-6.25452,"median":-2.89721,"eighty":-1.806764,"marketCap":203410421},{"date":"2023-06-02","current":-1.995661,"twenty":-6.25452,"median":-2.88216,"eighty":-1.806764,"marketCap":204439478},{"date":"2023-06-09","current":-2.035842,"twenty":-6.25452,"median":-2.865856,"eighty":-1.806764,"marketCap":208555710},{"date":"2023-06-16","current":-2.27358,"twenty":-6.25452,"median":-2.836384,"eighty":-1.806764,"marketCap":232910077},{"date":"2023-06-23","current":-2.08272,"twenty":-6.25953,"median":-2.815898,"eighty":-1.806567,"marketCap":213357979},{"date":"2023-06-30","current":-2.752405,"twenty":-6.264539,"median":-2.79725,"eighty":-1.80637,"marketCap":281961831},{"date":"2023-07-07","current":-2.882993,"twenty":-6.219784,"median":-2.79725,"eighty":-1.80637,"marketCap":295339582},{"date":"2023-07-14","current":-3.63304,"twenty":-6.19313,"median":-2.79725,"eighty":-1.80637,"marketCap":372175897},{"date":"2023-07-21","current":-3.95114,"twenty":-6.180681,"median":-2.79725,"eighty":-1.80637,"marketCap":404762726},{"date":"2023-07-28","current":-3.515845,"twenty":-6.158749,"median":-2.79725,"eighty":-1.80637,"marketCap":360170223},{"date":"2023-08-04","current":-4.05643,"twenty":-6.148902,"median":-2.79725,"eighty":-1.8052,"marketCap":429803132},{"date":"2023-08-11","current":-4.629056,"twenty":-6.137112,"median":-2.79725,"eighty":-1.8052,"marketCap":490476296},{"date":"2023-08-18","current":-4.361614,"twenty":-6.101011,"median":-2.79725,"eighty":-1.8052,"marketCap":462139221},{"date":"2023-08-25","current":-3.800317,"twenty":-6.098107,"median":-2.79725,"eighty":-1.8052,"marketCap":402666346},{"date":"2023-09-01","current":-3.272036,"twenty":-6.067271,"median":-2.79725,"eighty":-1.8052,"marketCap":346691876},{"date":"2023-09-08","current":-3.321563,"twenty":-6.026618,"median":-2.79725,"eighty":-1.8052,"marketCap":351939482},{"date":"2023-09-15","current":-3.631927,"twenty":-5.954331,"median":-2.79725,"eighty":-1.8052,"marketCap":384824484},{"date":"2023-09-22","current":-2.756963,"twenty":-5.954331,"median":-2.790917,"eighty":-1.8052,"marketCap":292116767},{"date":"2023-09-29","current":-2.641402,"twenty":-5.954331,"median":-2.778602,"eighty":-1.8052,"marketCap":279872352},{"date":"2023-10-06","current":-2.793282,"twenty":-5.954331,"median":-2.768311,"eighty":-1.8052,"marketCap":295965012},{"date":"2023-10-13","current":-2.674419,"twenty":-5.954331,"median":-2.767265,"eighty":-1.8052,"marketCap":283370756},{"date":"2023-10-20","current":-2.476314,"twenty":-5.954331,"median":-2.759953,"eighty":-1.8052,"marketCap":262380330},{"date":"2023-10-27","current":-2.039467,"twenty":-5.962331,"median":-2.756201,"eighty":-1.801691,"marketCap":216093723},{"date":"2023-11-03","current":-2.570254,"twenty":-5.962331,"median":-2.752288,"eighty":-1.801691,"marketCap":257405759},{"date":"2023-11-10","current":-2.326979,"twenty":-5.962331,"median":-2.743614,"eighty":-1.801691,"marketCap":233042251},{"date":"2023-11-17","current":-2.178898,"twenty":-5.962331,"median":-2.743614,"eighty":-1.801691,"marketCap":218212289},{"date":"2023-11-24","current":-2.164795,"twenty":-5.962331,"median":-2.743614,"eighty":-1.801691,"marketCap":216799912},{"date":"2023-12-01","current":-2.203578,"twenty":-5.962331,"median":-2.74344,"eighty":-1.801691,"marketCap":220683950},{"date":"2023-12-08","current":-9.955568,"twenty":-6.049293,"median":-2.752172,"eighty":-1.802861,"marketCap":997030242},{"date":"2023-12-15","current":-9.574831,"twenty":-6.092369,"median":-2.75544,"eighty":-1.802861,"marketCap":958900191},{"date":"2023-12-22","current":-9.77225,"twenty":-6.109725,"median":-2.759953,"eighty":-1.802861,"marketCap":978671329},{"date":"2023-12-29","current":-11.074277,"twenty":-6.140987,"median":-2.764196,"eighty":-1.806567,"marketCap":1109066691},{"date":"2024-01-05","current":-9.368011,"twenty":-6.14956,"median":-2.778602,"eighty":-1.80637,"marketCap":938187570},{"date":"2024-01-12","current":-9.570131,"twenty":-6.168114,"median":-2.793282,"eighty":-1.80637,"marketCap":958429449},{"date":"2024-01-19","current":-10.745245,"twenty":-6.181032,"median":-2.79725,"eighty":-1.8052,"marketCap":1076114794},{"date":"2024-01-26","current":-11.704138,"twenty":-6.200408,"median":-2.804116,"eighty":-1.80637,"marketCap":1172146036},{"date":"2024-02-02","current":-13.401003,"twenty":-6.254636,"median":-2.834547,"eighty":-1.80637,"marketCap":1342083674},{"date":"2024-02-09","current":-13.687731,"twenty":-6.30708,"median":-2.853195,"eighty":-1.80637,"marketCap":1370798898},{"date":"2024-02-16","current":-13.668929,"twenty":-6.37565,"median":-2.853195,"eighty":-1.80637,"marketCap":1368915933},{"date":"2024-02-23","current":-12.268193,"twenty":-6.417185,"median":-2.853195,"eighty":-1.80637,"marketCap":1228635001},{"date":"2024-03-01","current":-12.789944,"twenty":-6.540499,"median":-2.856467,"eighty":-1.806567,"marketCap":1280887294},{"date":"2024-03-08","current":-16.829528,"twenty":-6.600791,"median":-2.864789,"eighty":-1.806567,"marketCap":1191446432},{"date":"2024-03-15","current":-15.302231,"twenty":-6.677113,"median":-2.871843,"eighty":-1.806567,"marketCap":1083321418},{"date":"2024-03-22","current":-16.48474,"twenty":-6.761591,"median":-2.887382,"eighty":-1.806567,"marketCap":1167037148},{"date":"2024-03-28","current":-14.647627,"twenty":-6.81781,"median":-2.892586,"eighty":-1.806567,"marketCap":1036978781},{"date":"2024-04-05","current":-14.18307,"twenty":-6.857077,"median":-2.918529,"eighty":-1.80637,"marketCap":1004090458},{"date":"2024-04-12","current":-16.111686,"twenty":-6.901762,"median":-3.019122,"eighty":-1.80637,"marketCap":1140626828},{"date":"2024-04-19","current":-12.317803,"twenty":-6.964065,"median":-3.050414,"eighty":-1.807354,"marketCap":872038860},{"date":"2024-04-26","current":-11.374611,"twenty":-6.977129,"median":-3.092915,"eighty":-1.807507,"marketCap":805265598},{"date":"2024-05-03","current":-14.669933,"twenty":-6.99966,"median":-3.108194,"eighty":-1.807507,"marketCap":1038557911},{"date":"2024-05-10","current":-8.362276,"twenty":-7.014797,"median":-3.172728,"eighty":-1.811775,"marketCap":659909031},{"date":"2024-05-17","current":-8.263275,"twenty":-7.045704,"median":-3.193664,"eighty":-1.811775,"marketCap":652096375},{"date":"2024-05-24","current":-7.332667,"twenty":-7.080776,"median":-3.232956,"eighty":-1.817369,"marketCap":578657406},{"date":"2024-05-31","current":-7.095065,"twenty":-7.101547,"median":-3.286694,"eighty":-1.83021,"marketCap":559907031},{"date":"2024-06-07","current":-6.118256,"twenty":-7.101547,"median":-3.330137,"eighty":-1.834973,"marketCap":482822156},{"date":"2024-06-14","current":-6.131456,"twenty":-7.102515,"median":-3.412645,"eighty":-1.845001,"marketCap":483863843},{"date":"2024-06-21","current":-5.385649,"twenty":-7.102515,"median":-3.462472,"eighty":-1.863418,"marketCap":425008500},{"date":"2024-06-28","current":-5.775053,"twenty":-7.102515,"median":-3.473443,"eighty":-1.885785,"marketCap":455738281},{"date":"2024-07-05","current":-5.689252,"twenty":-7.102515,"median":-3.509148,"eighty":-1.903349,"marketCap":448967312},{"date":"2024-07-12","current":-6.54066,"twenty":-7.102515,"median":-3.561832,"eighty":-1.919277,"marketCap":516156156},{"date":"2024-07-15","current":-6.817862,"twenty":-7.102515,"median":-3.561832,"eighty":-1.920686,"marketCap":538031593},{"date":"2024-08-02","current":-6.025855,"twenty":-7.124873,"median":-3.608452,"eighty":-1.963141,"marketCap":475530343},{"date":"2024-08-09","current":-5.503143,"twenty":-7.124873,"median":-3.632484,"eighty":-1.96681,"marketCap":477788393},{"date":"2024-08-16","current":-5.054645,"twenty":-7.124873,"median":-3.645064,"eighty":-1.980482,"marketCap":438849322},{"date":"2024-08-23","current":-5.547781,"twenty":-7.124873,"median":-3.698817,"eighty":-1.980482,"marketCap":481663890},{"date":"2024-08-30","current":-5.375183,"twenty":-7.124873,"median":-3.810182,"eighty":-1.980482,"marketCap":466678791},{"date":"2024-09-06","current":-4.968346,"twenty":-7.124873,"median":-3.83418,"eighty":-1.980482,"marketCap":431356772},{"date":"2024-09-13","current":-5.473811,"twenty":-7.124873,"median":-3.903238,"eighty":-1.980482,"marketCap":475241704},{"date":"2024-09-20","current":-5.658737,"twenty":-7.124873,"median":-3.951544,"eighty":-1.980482,"marketCap":491297167},{"date":"2024-09-27","current":-4.97451,"twenty":-7.124873,"median":-3.986281,"eighty":-1.980482,"marketCap":431891954},{"date":"2024-10-04","current":-5.159436,"twenty":-7.124873,"median":-4.012982,"eighty":-1.980482,"marketCap":447947417},{"date":"2024-10-11","current":-5.079302,"twenty":-7.124873,"median":-4.052753,"eighty":-1.980482,"marketCap":440990050},{"date":"2024-10-18","current":-6.873084,"twenty":-7.124873,"median":-4.083441,"eighty":-1.980482,"marketCap":596728041},{"date":"2024-10-25","current":-5.892976,"twenty":-7.124873,"median":-4.137591,"eighty":-1.980482,"marketCap":511634087},{"date":"2024-10-31","current":-8.74412,"twenty":-7.137898,"median":-4.196959,"eighty":-1.980482,"marketCap":759173235},{"date":"2024-11-08","current":-7.626837,"twenty":-7.20923,"median":-4.361614,"eighty":-1.97961,"marketCap":789911501},{"date":"2024-11-15","current":-7.106109,"twenty":-7.272765,"median":-4.416406,"eighty":-1.97961,"marketCap":735979669},{"date":"2024-11-22","current":-5.656435,"twenty":-7.272765,"median":-4.456923,"eighty":-1.97961,"marketCap":585837010},{"date":"2024-11-29","current":-5.995144,"twenty":-7.272765,"median":-4.545502,"eighty":-1.97961,"marketCap":620917070},{"date":"2024-12-06","current":-5.527726,"twenty":-7.272765,"median":-4.586087,"eighty":-1.97961,"marketCap":572506587},{"date":"2024-12-13","current":-5.378694,"twenty":-7.272765,"median":-4.621598,"eighty":-1.97961,"marketCap":557071360},{"date":"2024-12-20","current":-4.823212,"twenty":-7.272765,"median":-4.654737,"eighty":-1.97961,"marketCap":499540061},{"date":"2024-12-27","current":-5.134824,"twenty":-7.272765,"median":-4.680438,"eighty":-1.97961,"marketCap":531813717},{"date":"2025-01-03","current":-5.439662,"twenty":-7.272765,"median":-4.688488,"eighty":-1.97961,"marketCap":563385771},{"date":"2025-01-10","current":-6.171273,"twenty":-7.274134,"median":-4.721011,"eighty":-1.978739,"marketCap":639158702},{"date":"2025-01-17","current":-4.924825,"twenty":-7.274134,"median":-4.757117,"eighty":-1.978739,"marketCap":510064079},{"date":"2025-01-24","current":-5.974822,"twenty":-7.274134,"median":-4.81202,"eighty":-1.978739,"marketCap":618812267},{"date":"2025-01-31","current":-5.45321,"twenty":-7.274134,"median":-4.825842,"eighty":-1.978739,"marketCap":564788974},{"date":"2025-02-07","current":-4.484503,"twenty":-7.274134,"median":-4.853805,"eighty":-1.978739,"marketCap":464460001},{"date":"2025-02-14","current":-4.274504,"twenty":-7.274134,"median":-4.853805,"eighty":-1.978739,"marketCap":442710363},{"date":"2025-02-21","current":-4.301601,"twenty":-7.274134,"median":-4.853805,"eighty":-1.978739,"marketCap":445516768},{"date":"2025-02-28","current":-4.22031,"twenty":-7.274134,"median":-4.853805,"eighty":-1.978739,"marketCap":437097553},{"date":"2025-03-07","current":-3.581647,"twenty":-7.275504,"median":-4.857083,"eighty":-1.977868,"marketCap":468730143},{"date":"2025-03-14","current":-3.586899,"twenty":-7.275504,"median":-4.857083,"eighty":-1.977868,"marketCap":469417430},{"date":"2025-03-21","current":-3.203526,"twenty":-7.275504,"median":-4.857083,"eighty":-1.982224,"marketCap":419245436},{"date":"2025-03-28","current":-3.103744,"twenty":-7.275504,"median":-4.857083,"eighty":-1.982224,"marketCap":406186971},{"date":"2025-04-04","current":-2.620589,"twenty":-7.275504,"median":-4.857083,"eighty":-1.986581,"marketCap":342956512},{"date":"2025-04-11","current":-2.520807,"twenty":-7.274134,"median":-4.853805,"eighty":-1.998664,"marketCap":329898048},{"date":"2025-04-17","current":-2.914683,"twenty":-7.274134,"median":-4.853805,"eighty":-2.003697,"marketCap":381444618},{"date":"2025-04-25","current":-3.4346,"twenty":-7.275504,"median":-4.857083,"eighty":-2.020056,"marketCap":449486090},{"date":"2025-05-02","current":-3.744449,"twenty":-7.275504,"median":-4.857083,"eighty":-2.020056,"marketCap":490036058},{"date":"2025-05-09","current":-2.859698,"twenty":-7.275504,"median":-4.857083,"eighty":-2.021433,"marketCap":419749277},{"date":"2025-05-16","current":-2.681567,"twenty":-7.275504,"median":-4.857083,"eighty":-2.025797,"marketCap":393603129},{"date":"2025-05-23","current":-2.625311,"twenty":-7.275504,"median":-4.857083,"eighty":-2.025797,"marketCap":385345721},{"date":"2025-05-30","current":-3.380087,"twenty":-7.275504,"median":-4.857083,"eighty":-2.025797,"marketCap":496132616},{"date":"2025-06-06","current":-3.867645,"twenty":-7.275504,"median":-4.857083,"eighty":-2.029337,"marketCap":567696822},{"date":"2025-06-13","current":-4.153616,"twenty":-7.275504,"median":-4.857083,"eighty":-2.030146,"marketCap":609671980},{"date":"2025-06-20","current":-4.181745,"twenty":-7.275519,"median":-4.85959,"eighty":-2.030146,"marketCap":613800685},{"date":"2025-06-27","current":-4.861513,"twenty":-7.275519,"median":-4.869751,"eighty":-2.049961,"marketCap":713577702},{"date":"2025-07-03","current":-4.556789,"twenty":-7.275519,"median":-4.869751,"eighty":-2.092939,"marketCap":668850073},{"date":"2025-07-11","current":-5.184989,"twenty":-7.275519,"median":-4.878866,"eighty":-2.11162,"marketCap":761057800},{"date":"2025-07-18","current":-4.828696,"twenty":-7.275519,"median":-4.878866,"eighty":-2.147002,"marketCap":708760880},{"date":"2025-07-25","current":-4.917769,"twenty":-7.275519,"median":-4.892425,"eighty":-2.165118,"marketCap":721835110},{"date":"2025-08-01","current":-4.60367,"twenty":-7.275519,"median":-4.894961,"eighty":-2.173127,"marketCap":675731247},{"date":"2025-08-08","current":-3.951022,"twenty":-7.275519,"median":-4.894961,"eighty":-2.187675,"marketCap":692934181},{"date":"2025-08-15","current":-4.264217,"twenty":-7.275519,"median":-4.894961,"eighty":-2.213274,"marketCap":747862561},{"date":"2025-08-22","current":-4.558978,"twenty":-7.275519,"median":-4.894961,"eighty":-2.238916,"marketCap":799558130},{"date":"2025-08-29","current":-4.558978,"twenty":-7.275519,"median":-4.894961,"eighty":-2.269562,"marketCap":799558130},{"date":"2025-09-05","current":-4.669022,"twenty":-7.275534,"median":-4.895546,"eighty":-2.300854,"marketCap":818857809},{"date":"2025-09-12","current":-5.238895,"twenty":-7.275519,"median":-4.91446,"eighty":-2.329404,"marketCap":918802575},{"date":"2025-09-19","current":-5.407891,"twenty":-7.275519,"median":-4.923075,"eighty":-2.352075,"marketCap":948441368},{"date":"2025-09-26","current":-5.183872,"twenty":-7.275519,"median":-4.932745,"eighty":-2.419563,"marketCap":909152735},{"date":"2025-10-03","current":-5.305707,"twenty":-7.275519,"median":-4.942197,"eighty":-2.463236,"marketCap":930520237},{"date":"2025-10-10","current":-5.49239,"twenty":-7.275519,"median":-4.956209,"eighty":-2.494254,"marketCap":963260764},{"date":"2025-10-17","current":-4.539327,"twenty":-7.275519,"median":-4.96602,"eighty":-2.56263,"marketCap":796111758},{"date":"2025-10-24","current":-4.519677,"twenty":-7.275519,"median":-4.96602,"eighty":-2.574573,"marketCap":792665387},{"date":"2025-10-31","current":-5.619401,"twenty":-7.275519,"median":-5.020563,"eighty":-2.612621,"marketCap":985536169},{"date":"2025-11-07","current":-4.346629,"twenty":-7.275519,"median":-5.033717,"eighty":-2.637757,"marketCap":894327662},{"date":"2025-11-14","current":-4.631211,"twenty":-7.275519,"median":-5.033717,"eighty":-2.650995,"marketCap":952880902},{"date":"2025-11-21","current":-5.488246,"twenty":-7.275519,"median":-5.054089,"eighty":-2.672098,"marketCap":1129217680},{"date":"2025-11-28","current":-5.96706,"twenty":-7.275519,"median":-5.068604,"eighty":-2.688416,"marketCap":1227734472},{"date":"2025-12-05","current":-6.727528,"twenty":-7.275519,"median":-5.094712,"eighty":-2.710416,"marketCap":1384202318},{"date":"2025-12-12","current":-6.478062,"twenty":-7.275519,"median":-5.147222,"eighty":-2.740497,"marketCap":1332874242},{"date":"2025-12-19","current":-6.864332,"twenty":-7.275519,"median":-5.165076,"eighty":-2.756051,"marketCap":1412349973},{"date":"2025-12-26","current":-7.347169,"twenty":-7.289324,"median":-5.172773,"eighty":-2.793921,"marketCap":1511694637},{"date":"2026-01-02","current":-7.351192,"twenty":-7.324613,"median":-5.18443,"eighty":-2.826121,"marketCap":1512522509},{"date":"2026-01-09","current":-6.872379,"twenty":-7.324613,"median":-5.207453,"eighty":-2.826121,"marketCap":1414005717},{"date":"2026-01-16","current":-6.373447,"twenty":-7.324613,"median":-5.221197,"eighty":-2.826121,"marketCap":1311349564},{"date":"2026-01-23","current":-6.572618,"twenty":-7.324613,"median":-5.24479,"eighty":-2.826121,"marketCap":1352329238},{"date":"2026-01-30","current":-5.934871,"twenty":-7.324613,"median":-5.267112,"eighty":-2.826121,"marketCap":1221111495},{"date":"2026-02-06","current":-5.122095,"twenty":-7.286659,"median":-5.256581,"eighty":-2.826121,"marketCap":1053881310},{"date":"2026-02-13","current":-5.234757,"twenty":-7.238055,"median":-5.24837,"eighty":-2.826121,"marketCap":1077061732},{"date":"2026-02-20","current":-5.914752,"twenty":-7.198521,"median":-5.24479,"eighty":-2.826121,"marketCap":1216972134},{"date":"2026-02-27","current":-7.186223,"twenty":-7.149753,"median":-5.24479,"eighty":-2.826121,"marketCap":1478579749},{"date":"2026-03-06","current":-5.668547,"twenty":-7.140441,"median":-5.24479,"eighty":-2.826121,"marketCap":1314887532},{"date":"2026-03-13","current":-5.046302,"twenty":-7.140441,"median":-5.24086,"eighty":-2.826121,"marketCap":1170550258},{"date":"2026-03-20","current":-4.959979,"twenty":-7.13159,"median":-5.215152,"eighty":-2.826121,"marketCap":1150526590},{"date":"2026-03-27","current":-4.697413,"twenty":-7.13159,"median":-5.207022,"eighty":-2.826121,"marketCap":1089621267},{"date":"2026-04-02","current":-4.683026,"twenty":-7.13159,"median":-5.185686,"eighty":-2.826121,"marketCap":1086283989},{"date":"2026-04-10","current":-5.118238,"twenty":-7.13159,"median":-5.172773,"eighty":-2.826121,"marketCap":1187236648},{"date":"2026-04-17","current":-5.326852,"twenty":-7.13159,"median":-5.171072,"eighty":-2.826121,"marketCap":1235627179},{"date":"2026-04-24","current":-4.977963,"twenty":-7.13159,"median":-5.160679,"eighty":-2.826121,"marketCap":1154698188},{"date":"2026-05-01","current":-4.747768,"twenty":-7.13159,"median":-5.151767,"eighty":-2.826121,"marketCap":1101301740},{"date":"2026-05-08","current":-4.137326,"twenty":-7.13159,"median":-5.128459,"eighty":-2.826121,"marketCap":1123693672},{"date":"2026-05-15","current":-4.087124,"twenty":-7.13159,"median":-5.100254,"eighty":-2.826121,"marketCap":1110058785},{"date":"2026-05-22","current":-3.945124,"twenty":-7.13159,"median":-5.073284,"eighty":-2.826121,"marketCap":1071491788},{"date":"2026-05-29","current":-4.167385,"twenty":-7.132974,"median":-5.060809,"eighty":-2.825942,"marketCap":1131857523},{"date":"2026-06-05","current":-3.784603,"twenty":-7.13159,"median":-5.043144,"eighty":-2.826121,"marketCap":1027894313},{"date":"2026-06-12","current":-3.85869,"twenty":-7.13159,"median":-5.01676,"eighty":-2.826121,"marketCap":1048016225},{"date":"2026-06-18","current":-4.059341,"twenty":-7.13159,"median":-4.976237,"eighty":-2.826121,"marketCap":1102513068},{"date":"2026-06-26","current":-4.232211,"twenty":-7.132974,"median":-4.96547,"eighty":-2.825942,"marketCap":1149464195},{"date":"2026-07-02","current":-4.073233,"twenty":-7.132974,"median":-4.952785,"eighty":-2.825942,"marketCap":1106285927},{"date":"2026-07-10","current":-4.581036,"twenty":-7.132974,"median":-4.94121,"eighty":-2.825942,"marketCap":1244204862},{"date":"2026-07-17","current":-4.025385,"twenty":-7.132974,"median":-4.938731,"eighty":-2.825942,"marketCap":1093290525},{"date":"2026-07-24","current":-3.849429,"twenty":-7.132974,"median":-4.917769,"eighty":-2.825942,"marketCap":1045500986},{"date":"2026-07-31","current":-3.96982,"twenty":-7.134359,"median":-4.902522,"eighty":-2.825763,"marketCap":1078199092},{"date":"2026-08-07","current":-3.507935,"twenty":-7.134359,"median":-4.891056,"eighty":-2.825763,"marketCap":1075683853},{"date":"2026-08-14","current":-3.789878,"twenty":-7.129027,"median":-4.880588,"eighty":-2.825763,"marketCap":1162139620},{"date":"2026-08-21","current":-1.5182,"twenty":-7.129027,"median":-4.856954,"eighty":-2.793602,"marketCap":465545545},{"date":"2026-08-24","current":-1.495709,"twenty":-7.129027,"median":-4.853357,"eighty":-2.791301,"marketCap":458648574}],"updateTime":1787650375945},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"EYPT\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2660746491","title":"BUZZ——美國股市動態-Dynatrace、Duolingo、百度公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2660746491","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660746491?lang=zh_tw&edition=fundamental","pubTime":"2026-08-18 19:43","pubTimestamp":1787053391,"startTime":"0","endTime":"0","summary":".N** EyePoint IncEYPT.O:市场热议 - 因试验性药物未达目标，券商下调评级，股价下跌nL6N44F06Z** DocGo IncDCGO.O:热点 - 因季度业绩平淡、年度展望下调而下跌nL4N44F0EJ** 百度公司BIDU.O:热点 - 因第二季度营收表现疲软，股价下跌nL4N44F0H1** Corebridge Financial IncCRBG.N:** 公平控股公司EQH.N：** 布赖特豪斯金融公司BHF.O:** 林肯国民公司LNC.N:热点 - 埃弗科表示马克·沃尔特相关报道被过度解读，人寿保险股走弱nL6N44F0K3** Dynatrace IncDT.N:热点 - 因12.5亿美元可转换债券发行定价而上涨nL6N44F0O2** Duolingo IncDUOL.O:热点 - 因D.A. Davidson上调评级并提高目标价，股价上涨nL4N44F0MI","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nL4S44F0OQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4023","BK4613","BK4548","BK4602","DCGO","BK4560","LU0287142896.SGD","LU0889565916.HKD","LU0130518102.USD","LU1169589451.USD","LU1201861165.SGD","IE00B7SZLL34.SGD","BK4561","BK4574","BK4579","LU0109394709.USD","BIDU","LU2355687059.USD","LU0173614495.USD","IE00B19Z3B42.SGD","CRBG","KBDU","LU0640798160.USD","LU0359202008.SGD","09888","BK4184","DRGN","LU0130103400.USD","BK4539","BK4504","BK4196","BK4162","BK4585","IE00B19Z3581.USD","BK4588","BK4552","LU0320765992.SGD","BK4614","EQH","BK4514","LU1115378108.SGD","LU0477156797.USD","BK4526","BK4543","IE0002270589.USD","LU0359201612.USD","BK4587","BIDG","LU0648000940.SGD","BHF","BK4612","EYPT","LNC","LU1169590202.USD","IE00B0JY6N72.USD","BK4204","LU1023057109.AUD","BK4531","BK4077","BK4535","DUOL","DT","DUOG","LU0348723411.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660465855","title":"眼科管線失利刷屏，貝達藥業20CM跌停，公司回應","url":"https://stock-news.laohu8.com/highlight/detail?id=2660465855","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660465855?lang=zh_tw&edition=fundamental","pubTime":"2026-08-18 17:17","pubTimestamp":1787044631,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["EYPT","BK4588","LU0320765992.SGD","BK4585","LU0109394709.USD","LU0889565916.HKD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660468331","title":"EyePoint股價下跌，因試驗性藥物未達預期，券商下調評級","url":"https://stock-news.laohu8.com/highlight/detail?id=2660468331","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660468331?lang=zh_tw&edition=fundamental","pubTime":"2026-08-18 16:18","pubTimestamp":1787041106,"startTime":"0","endTime":"0","summary":"BUZZ-EyePoint股价下跌，因试验性药物未达预期，券商下调评级8月18日-** 制药公司EyePointEYPT.O的股价在盘前交易中下跌近2.5%，至4.75美元** 摩根大通将该股评级从“增持”下调至“中性”，而加拿大皇家银行资本市场则将其评级从“跑赢大盘”下调至“与行业持平”，并将目标价从37美元大幅下调至5美元** EYPT表示，用于治疗湿性年龄相关性黄斑变性的试验性药物 (lin","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nL4S44F0EG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","EYPT","LU0109394709.USD","BK4007","BK4588","LU0320765992.SGD","LU0889565916.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660045048","title":"美國研究綜述-Everpure、Marvell Technology、Okta","url":"https://stock-news.laohu8.com/highlight/detail?id=2660045048","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660045048?lang=zh_tw&edition=fundamental","pubTime":"2026-08-18 15:55","pubTimestamp":1787039705,"startTime":"0","endTime":"0","summary":"美国研究综述-Everpure、Marvell Technology、Okta路透8月18日-周二，华尔街的证券分析师上调了多家在美国上市公司的评级和目标股价，其中包括Everpure、Marvell Technology和Okta。股票条目按字母顺序排列。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nL4S44F0DH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BLSP4239.USD","BK4528","BK4007","SG9999000418.SGD","LU1642822529.SGD","MVLL","ODDS","SMHX","FAI","BK4139","LU0061475181.USD","LU2089985449.USD","MRVU","LU0012050646.USD","GTEK","LU0240878834.USD","ODDZ","LU0109394709.USD","LU2286300806.USD","URBN","WBI","LU1861215975.USD","BK4094","LU0205194284.USD","SPAM","IE00BBT3K403.USD","LU0056508442.USD","LU1316542783.SGD","LU0642271901.SGD","BK4515","LU0444973449.USD","LU0187121727.USD","LU1015430645.USD","FXL","BETZ","IE00BMPRXR70.SGD","LU0476273544.USD","BK4173","FLUT","P","LU1861220033.SGD","EYPT","LU1992135399.USD","LU0348723411.USD","HAKY","BK4605","LU1720051017.SGD","BK4168","BK4563","LU2272731865.HKD","LU2458330243.SGD","LU1169589451.USD","LU0575583348.USD","LU0786609619.USD","LU0205193047.USD","LU2473716301.USD","LU1548497426.USD","LU0444971666.USD","LU1046421795.USD","LU1815336760.USD","IHAK","LU0274383776.USD","ATAI","BK4141","LU0082616367.USD","LU2931357623.SGD","LU0154236417.USD","LIFE","BK4588","SGXZ81514606.USD","SOXY","ARTY","BK4172","CPB","BK4604","LU0823434583.USD","XTL","YSS","AIFD","LU1261432733.SGD","LU0154245756.USD","LU0127658192.USD","BK4585","LU0963586101.USD","IE0004086264.USD","BK4187","LU1992135472.HKD","BK4539","BK4543","MRVL","LU1235294995.USD","LU2322448957.HKD","LU2272731600.USD","AIS","LU0081259029.USD","WUGI","ANF","LU1119994496.HKD","LU0106261612.USD","LU1169590202.USD","NUVB","BK4212","LU0719512351.SGD","LU1989764748.USD","SSMR","LU2098885051.SGD","LU2360107168.USD","IE00BMPRXN33.USD","LU0154245673.USD","IE00BMPRXQ63.HKD","BK4170","LU2244417387.USD","QQQA","LU1852331112.SGD","CIEN","FOTO","IE00BN8TJ469.HKD","BUG","LU1823568750.SGD","OKTX","LU0240877869.USD","XNTK","LU0823421333.USD","OKTG","IE0004091025.USD","BK4020","SGXZ99366536.SGD","OKTA","BK4581","LU2357305700.SGD","DTCR","BK4116","LU0957808578.USD","LU1084165304.USD","LU0889565916.HKD","LU1303367103.USD","LU2272731782.SGD","LU2290526834.HKD","IE00BLSP4452.SGD","LU2322448791.USD","FDTX","PSWD","TEXX","LU2458330169.SGD","NVIR","LU1989764664.SGD","MRVX","BK4150","LU2543165471.USD","LU0320765992.SGD","SGXZ51526630.SGD","LU1720051108.HKD","BK4560","FTXL","LU0823421416.USD","LU0823434740.USD","BK4179"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660556264","title":"貝達藥業20CM跌停，EyePoint美股隔夜大跌67%，伏羅尼布wAMD三期臨床失敗，貝達藥業擁有大中華區權益。","url":"https://stock-news.laohu8.com/highlight/detail?id=2660556264","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660556264?lang=zh_tw&edition=fundamental","pubTime":"2026-08-18 09:39","pubTimestamp":1787017169,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU0109394709.USD","LU0889565916.HKD","BK4007","BK4588","BK4585","EYPT","LU0320765992.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660332334","title":"EyePoint股價料將創下歷史最大跌幅，因其一款實驗性眼科藥物未能達到後期臨床試驗目標","url":"https://stock-news.laohu8.com/highlight/detail?id=2660332334","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660332334?lang=zh_tw&edition=fundamental","pubTime":"2026-08-17 22:15","pubTimestamp":1786976114,"startTime":"0","endTime":"0","summary":"BUZZ-EyePoint股价料将创下历史最大跌幅，因其一款实验性眼科药物未能达到后期临床试验目标最新动态8月17日-**EyePoint公司（EYPT.O）股价暴跌71%至4.17美元，有望创下有史以来最大单日跌幅，并跌至2025年4月以来的最低点**这家药物开发商表示，其实验性眼科药物Duravyu在针对湿性年龄相关性黄斑变性（视力丧失的主要原因之一）患者开展的晚期临床试验中，未能达到主要目标","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nL4T44E101:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","LU0058720904.USD","LU1917777945.USD","IBB","REGN","EYPT","BK4588","LU2362541273.HKD","TBXU","BK4007","LU2106854487.HKD","BBH","LU2362540622.SGD","LU2237438978.USD","LU0114720955.EUR","LU0289739699.SGD","IBBQ","LU0823434583.USD","LU0889565916.HKD","LU0053666078.USD","LU1974910355.USD","LU0320765992.SGD","LU0823416689.USD","LU0823434740.USD","LU2468319806.SGD","LU0109394709.USD","LU0882574055.USD","LU2023250504.SGD","BK4139","LU2362541513.USD","LU2089984988.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660848445","title":"EyePoint公司治療年齡相關性眼病的藥物晚期臨床試驗失敗，股價暴跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2660848445","media":"路透中文","labels":["dataReport","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660848445?lang=zh_tw&edition=fundamental","pubTime":"2026-08-17 19:14","pubTimestamp":1786965255,"startTime":"0","endTime":"0","summary":"EyePoint公司未能证明Duravyu在保护视力方面不比Eylea明显逊色。而在接受Eylea治疗的患者中，未出现此类情况。EyePoint的股价在早盘交易中跌至4.16美元。EyePoint计划于2027年上半年向美国FDA提交批准申请，具体取决于预计于今年晚些时候公布的第二项晚期临床试验结果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nL4T44E0O1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0058720904.USD","LU1974910355.USD","BK4588","LU0114720955.EUR","LU2362541273.HKD","BK4007","LU0109394709.USD","LU2468319806.SGD","BK4139","LU2089984988.USD","LU1917777945.USD","LU0823434740.USD","LU2106854487.HKD","LU0889565916.HKD","LU2362541513.USD","TBXU","LU2362540622.SGD","IBB","LU0320765992.SGD","OTLK","IBBQ","EYPT","BK4585","LU2237438978.USD","BBH","LU0823416689.USD","LU0882574055.USD","LU2023250504.SGD","LU0053666078.USD","LU0823434583.USD","LU0289739699.SGD","REGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660505484","title":"EyePoint眼科藥物在後期臨床試驗中未達到主要目標","url":"https://stock-news.laohu8.com/highlight/detail?id=2660505484","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660505484?lang=zh_tw&edition=fundamental","pubTime":"2026-08-17 19:03","pubTimestamp":1786964588,"startTime":"0","endTime":"0","summary":"EyePoint眼科药物在后期临床试验中未达到主要目标路透8月17日-EyePoint公司（EYPT.O）周一表示，其一款试验性眼科药物在后期临床试验中未能达到主要目标。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nL4S44E0N3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EYPT","LU0889565916.HKD","BK4588","LU0320765992.SGD","BK4007","BK4585","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1174905289","title":"EyePoint公布Lugano試驗頂線數據——濕性AMD候選藥物Duravyu™ 2.7Mg兩項關鍵III期臨床研究首項結果揭曉","url":"https://stock-news.laohu8.com/highlight/detail?id=1174905289","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1174905289?lang=zh_tw&edition=fundamental","pubTime":"2026-08-17 19:01","pubTimestamp":1786964507,"startTime":"0","endTime":"0","summary":"EyePoint Pharmaceuticals今日宣布，其备受关注的关键性III期临床试验Lugano研究的顶线数据已正式出炉。这项研究是评估Duravyu 2.7Mg在湿性年龄相关性黄斑变性治疗中疗效与安全性的两项 pivotal 试验中的第一项，其结果的公布标志着该公司在眼科治疗领域迈出了至关重要的一步。随着Lugano研究的尘埃落定，行业目光现已转向第二项关键性III期试验的最终结果，该数据的问世将进一步明确Duravyu 2.7Mg在湿性AMD治疗格局中的潜在定位。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","LU0889565916.HKD","LU0109394709.USD","BK4585","BK4588","LU0320765992.SGD","EYPT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657415745","title":"EyePoint 2026年第二季度財報：三期投入擴大淨虧損","url":"https://stock-news.laohu8.com/highlight/detail?id=2657415745","media":"TradingKey中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657415745?lang=zh_tw&edition=fundamental","pubTime":"2026-08-05 19:46","pubTimestamp":1785930381,"startTime":"0","endTime":"0","summary":"EyePoint 2026年第二季度营收50.7万美元，同比下降约90.5%；每股亏损1.09美元，净亏损9447万美元。三期试验推高研发支出，现金及投资为1.8亿美元。","market":"us","thumbnail":"https://resource.tradingkey.com/cdn/images/article/news/stock9.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cdn/images/article/news/stock9.jpg"],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/zh-hans/news/earnings/262077980-tradingkey","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EYPT","SQMX","PSET"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1110675913","title":"EyePoint宣佈Duravyu™兩類關鍵性III期臨床試驗完成受試者入組，旨在治療糖尿病性黃斑水腫（DME）","url":"https://stock-news.laohu8.com/highlight/detail?id=1110675913","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1110675913?lang=zh_tw&edition=fundamental","pubTime":"2026-07-30 19:09","pubTimestamp":1785409767,"startTime":"0","endTime":"0","summary":"EyePoint已完成其旨在治疗糖尿病性黄斑水肿（DME）的Duravyu™药物的两项关键性III期临床试验的受试者入组。这一里程碑标志着该药物研发进入新的阶段。Duravyu™作为一种潜在的新疗法，正致力于为DME患者提供更有效的治疗选择。此次入组完成，将推动后续数据读取及分析工作的开展，为评估该药的疗效与安全性奠定基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320765992.SGD","LU0109394709.USD","BK4588","BK4585","LU0889565916.HKD","BK4007","EYPT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635971743","title":"EyePoint的晚期眼科藥物臨床試驗將在安全委員會審查後繼續進行","url":"https://stock-news.laohu8.com/highlight/detail?id=2635971743","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635971743?lang=zh_tw&edition=fundamental","pubTime":"2026-05-14 20:35","pubTimestamp":1778762133,"startTime":"0","endTime":"0","summary":"路透5月14日 - EyePoint公司周四表示，其独立安全委员会在对实验性眼病药物Duravyu的两项晚期临床试验中未发现新的安全隐患，并建议这些研究按原计划继续进行。EyePoint表示，首项研究的主要数据仍按计划将于2026年年中公布，第二项研究的结果预计紧随其后。该系列研究已入组超过900名患者，旨在将Duravyu与Regeneron旗下 REGN.O 公司的重磅眼科药物Eylea进行对比评估。EyePoint表示，中期安全性数据显示其安全性特征持续良好，与此前四项试验中190多名患者的观察结果一致。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260514:nL4S41R1A6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0823434740.USD","LU2362540622.SGD","LU0823416689.USD","LU1917777945.USD","LU0109394709.USD","LU0889565916.HKD","LU0053666078.USD","BK4007","EYPT","LU2362541513.USD","BK4585","LU0882574055.USD","OCUL","BK4139","LU2237438978.USD","REGN","LU0289739699.SGD","LU0320765992.SGD","LU2468319806.SGD","LU0114720955.EUR","LU0058720904.USD","BK4588","LU1974910355.USD","LU2362541273.HKD","LU2023250504.SGD","LU0823434583.USD","LU2106854487.HKD","LU2089984988.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1112077828","title":"EyePoint宣佈Duravyu™濕性年齡相關性黃斑變性三期試驗獲獨立數據監查委員會第三次積極建議，為2026年中頂線數據增添信心","url":"https://stock-news.laohu8.com/highlight/detail?id=1112077828","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1112077828?lang=zh_tw&edition=fundamental","pubTime":"2026-05-14 19:01","pubTimestamp":1778756486,"startTime":"0","endTime":"0","summary":"EyePoint近日宣布，其针对湿性年龄相关性黄斑变性的候选药物Duravyu进行的关键三期临床试验，再次获得了独立数据监查委员会的积极建议。这是该委员会连续第三次对试验的进展与安全性给予正面评价。此次积极的监管反馈，进一步增强了市场对Duravyu临床开发计划的信心。这一里程碑式的进展，凸显了EyePoint在眼科治疗领域的研发实力与Duravyu的潜在价值。随着试验按计划推进，投资者对2026年的数据发布抱有更高期待。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0889565916.HKD","LU0109394709.USD","BK4007","LU0320765992.SGD","BK4588","BK4585","EYPT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623239478","title":"美國研究綜述-弗格森企業、哈特福德保險集團、摩根大通","url":"https://stock-news.laohu8.com/highlight/detail?id=2623239478","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623239478?lang=zh_tw&edition=fundamental","pubTime":"2026-03-30 15:36","pubTimestamp":1774856215,"startTime":"0","endTime":"0","summary":"美国研究综述-弗格森企业、哈特福德保险集团、摩根大通路透3月30日 - 华尔街证券分析师周一调整了对弗格森企业、哈特福德保险集团和摩根大通等几家美国上市公司的评级和目标价。要闻 * 弗格森企业FERG.N：摩根士丹利将目标价从270美元上调至280美元* 哈特福德保险集团HIG.N：KBW将其评级从 \"跑赢大盘 \"下调至 \"市场表现\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260330:nL4T40I0JZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4142","GRDN","CCL.UK","SG9999002224.SGD","FERG","LU0820561909.HKD","RF","VRDN","HIG","LU2244417387.USD","LU1989764748.USD","LU2294711713.HKD","LU0823414478.USD","CCL","LU2746668461.USD","FDMT","FLUT","KPTI","BK4566","VOR","IE00BJTD4V19.USD","LU2213496289.HKD","MMM","PTCT","LU0320765992.SGD","LEGN","VSTM","LU0323591593.USD","BPH","LGN","BSX","LU2505996509.AUD","BK4082","BP","LU0950375773.USD","LU0353189680.USD","LU1829250122.USD","JPMO","LU2237443978.SGD","GLUE","EYPT","LU0882574139.USD","FITB","KMI","LU0868494708.USD","CHWY","LU1162221912.USD","JPM","LU2362541513.USD","LU2487616109.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621752336","title":"EyePoint 起訴競爭對手 Ocular Therapeutix，稱其虛假宣傳眼科藥物","url":"https://stock-news.laohu8.com/highlight/detail?id=2621752336","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621752336?lang=zh_tw&edition=fundamental","pubTime":"2026-03-21 05:22","pubTimestamp":1774041725,"startTime":"0","endTime":"0","summary":"路透3月20日 - EyePoint EYPT.O周五提起诉讼，指控竞争对手Ocular Therapeutix OCUL.O散布有关EyePoint及其主要实验性眼药的虚假或误导性信息。EyePoint 公司称，Ocular Therapeutix 公司发表的声明歪曲了该公司和药物 Duravyu 的临床结果。该公司指控 Ocular Therapeutix 诽谤、商业诋毁和违反马萨诸塞州消费者保护法。该公司还指控 Ocular Therapeutix 干扰了其业务关系。Ocular 没有立即回应路透的置评请求。EyePoint 要求法院命令 Ocular Therapeutix 停止发表上述言论，公开撤回声明，并支付赔偿金和法律费用。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260320:nL4T4081U1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","REGN","LU2362540622.SGD","LU2362541513.USD","LU2106854487.HKD","LU1917777945.USD","LU2023250504.SGD","EYPT","LU1974910355.USD","LU0823416689.USD","LU2237438978.USD","LU0053666078.USD","LU0882574055.USD","LU0058720904.USD","LU0889565916.HKD","LU0289739699.SGD","LU0823434583.USD","LU2089984988.USD","BK4139","BK4007","OCUL","LU0109394709.USD","LU2468319806.SGD","LU0823434740.USD","LU0320765992.SGD","LU0114720955.EUR","BK4585","LU2362541273.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143779601","title":"EyePoint公司遭起訴：指控涉及誹謗、商業詆譭及侵權干擾","url":"https://stock-news.laohu8.com/highlight/detail?id=1143779601","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1143779601?lang=zh_tw&edition=fundamental","pubTime":"2026-03-21 04:40","pubTimestamp":1774039203,"startTime":"0","endTime":"0","summary":"根据最新提交至美国证券交易委员会（SEC）的文件显示，EyePoint公司面临一项法律诉讼。该起诉书中明确提出多项指控，包括诽谤、商业诋毁以及侵权干扰等主张。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","LU0109394709.USD","LU0889565916.HKD","BK4007","BK4588","EYPT","LU0320765992.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1195908932","title":"訴訟指控Ocular Therapeutix就EyePoint及Duravyu發布虛假聲明——SEC文件披露","url":"https://stock-news.laohu8.com/highlight/detail?id=1195908932","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1195908932?lang=zh_tw&edition=fundamental","pubTime":"2026-03-21 04:36","pubTimestamp":1774039019,"startTime":"0","endTime":"0","summary":"根据最新提交至美国证券交易委员会（SEC）的文件，一项诉讼指控生物技术公司Ocular Therapeutix针对EyePoint公司及其产品Duravyu散布了不实信息。该法律文件指出，Ocular Therapeutix通过公开声明传播了有关EyePoint业务及Duravyu产品的虚假内容。目前案件细节仍在进一步披露中，此事可能对两家公司的市场声誉及投资者关系产生重要影响。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EYPT","LU0889565916.HKD","BK4588","LU0320765992.SGD","BK4007","BK4585","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1165654593","title":"EyePoint公司於2026年3月20日向馬薩諸塞州米德爾塞克斯縣高等法院對Ocular Therapeutix提起訴訟","url":"https://stock-news.laohu8.com/highlight/detail?id=1165654593","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1165654593?lang=zh_tw&edition=fundamental","pubTime":"2026-03-21 04:36","pubTimestamp":1774039017,"startTime":"0","endTime":"0","summary":"2026年3月20日，EyePoint公司已正式向美国马萨诸塞州米德尔塞克斯县高等法院递交诉状，对生物技术公司Ocular Therapeutix提起诉讼。此举标志着两家在眼科治疗领域具有重要影响力的企业之间法律纠纷的公开化。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0889565916.HKD","BK4588","EYPT","BK4585","LU0320765992.SGD","BK4007","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1106945439","title":"EyePoint宣佈Duravyu™治療糖尿病黃斑水腫的兩項全球三期臨床試驗首批患者完成給藥","url":"https://stock-news.laohu8.com/highlight/detail?id=1106945439","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1106945439?lang=zh_tw&edition=fundamental","pubTime":"2026-03-02 20:02","pubTimestamp":1772452939,"startTime":"0","endTime":"0","summary":"EyePoint Pharmaceuticals宣布，其创新药物Duravyu™针对糖尿病黄斑水肿治疗的两项全球三期临床试验已成功完成首批患者给药。这一重要进展标志着该疗法向商业化迈出关键一步，为全球数百万糖尿病患者带来新的希望。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0109394709.USD","LU0320765992.SGD","LU0889565916.HKD","EYPT","BK4588","BK4007","BK4585"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":19,"code":"91000000","status":"200"}]}}